Accessibility Tools

Technology

GeoVax utilizes two robust core technology platforms:

  • Modified Vaccinia Ankara (MVA) for creating vaccines for the prevention of various infectious diseases, and the basis for creating cancer immunotherapies.
  • Gene-Directed Enzyme Prodrug Therapy (GDEPT)  for the treatment of solid tumors with an initial focus on advanced head and neck cancer.
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
GeoVax © 2024 All Rights Reserved.
WebCenntrix Web Design

Search